Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound anisodine for ophthalmoplegia
ChiCTR-TRC-14004556Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of anisodine in paralytic squint (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Palpebral fissure size. Started Apr 2014; status: completed.
02
Drugs
anisodine
03
Conditions
paralytic squint
Beyond the preview
Go deeper on ChiCTR-TRC-14004556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004556.